MARSHALL WACE, LLP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$461,000
-88.1%
293,934
-82.3%
0.00%
-85.7%
Q1 2022$3,864,000
+653.2%
1,658,516
+3639.4%
0.01%0.0%
Q1 2015$513,00044,3520.01%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders